©The Author(s) 2017.
World J Diabetes. Apr 15, 2017; 8(4): 154-164
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.154
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.154
Table 2 Baseline characteristics of participants
| Measurement | Mean ± SD |
| Anthropomorphic | |
| Age (yr) | 53.8 ± 9.11 |
| Weight | 100.6 ± 21.75 kg |
| BMI | 36.9 ± 8.29 kg/m2 |
| Waist circumference (reference < 88 female, < 102 male) | 109.6 ± 11.1 cm |
| Daily hours fasted | 11.6 ± 1.9 h/d |
| Systolic BP (mmHg) T2DM goal < 130 | 130.00 ± 17.80 |
| Diastolic BP (mmHg) T2DM goal < 80 | 80.50 ± 13.20 |
| Biochemical | |
| C-reactive protein (mg/L) (reference < 1.0 mg/L) | 4.31 ± 3.80 |
| HOMA-IR calculated (normal < 2.5) | 6.91 ± 3.00 |
| Fasting glucose (normal < 7.0 mmol/L) | 7.45 ± 1.52 mmol/L |
| Medications present during study period | |
| Metformin | 10 (10) |
| Sulfonylureas | 1 (10) |
| Other diabetic medications | 1 (10) |
| Other non-diabetic medications | 8 (10) |
- Citation: Arnason TG, Bowen MW, Mansell KD. Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study. World J Diabetes 2017; 8(4): 154-164
- URL: https://www.wjgnet.com/1948-9358/full/v8/i4/154.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i4.154